about
Current translational and clinical practices in hematopoietic cell and gene therapyThe Utilization of the Immune System in Lung Cancer Treatment: Beyond ChemotherapyOvercoming tumor immune evasion with an unique arbovirusAutophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy.Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer.Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer.Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligoTherapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein.Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance.Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment.Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combinationEnhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.Covert operations: cancer's many subversive tactics in overcoming host defenses.Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapyFunctional features of cancer stem cells in melanoma cell lines.Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapyThe STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions.Immunotherapeutic applications of IL-15.Therapeutic cancer vaccines: a long and winding road to success.Microfluidics: A new tool for modeling cancer-immune interactions.Characterization of Ewing sarcoma associated cancer/testis antigensThe immunostimulatory effect of biogenic selenium nanoparticles on the 4T1 breast cancer model: an in vivo study.Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cells.Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.Immunotherapy of cancers comes of age.Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma.Tumor-targeting vaccination instructs graft-vs.-tumor immune responses.Clinical Roles of Interleukin-6 and STAT3 in Oral Squamous Cell Carcinoma.New advances in immunotherapy for non-small cell lung cancer
P2860
Q27024456-18978CE4-5A8C-46EF-BA8A-CA25F1D28312Q28066568-F913A96E-6458-4E2F-872C-5752547B9C1CQ28081774-A46C14F1-44F9-4E90-AEBB-28307382AD0AQ30402590-8658D298-4D03-4F52-9CD0-A3D6FA37F6A5Q34228613-C838C4D0-6F65-4BA8-BFC6-A72A2EEA9994Q34351795-2CDF8E5D-50B9-4CD5-AA3F-384935DB7058Q34352772-D047D674-0B4F-45F2-90CF-7258ED0AAE0DQ35053658-395DC019-58A1-4FF2-9058-4F152D63151AQ35878535-27B76D88-FBED-494E-A617-ACA44F90DFC1Q36544963-2A0A517F-B749-44D4-91EE-4F00E05F5A92Q36735574-9A7149E7-248A-457D-90A0-5AA5DD5A0406Q36750814-63744E83-2B96-428E-AD1C-6D378DCD6476Q36941051-C33CCBC6-CDF5-4022-80C4-F6F7653E8EEBQ37026063-93474D86-DFE8-43EF-A8C6-34ED21FAE72CQ37107516-5EC78B17-2DA9-401B-90E5-D0528C1B003EQ37151909-52515BD5-9B62-42FA-92AE-83E88A8C0662Q37185223-897914AF-8C20-498B-9789-ABA240A50C92Q38026940-24509C13-A32E-44BE-ADF4-7282EA629DB4Q38050510-9CC1DEEF-5B13-414A-8B77-414EBDF4C03CQ38162261-0DD8D24A-95DE-4004-BFB8-944CDE6B73CEQ38269600-57FF1333-7E04-45F2-A0E2-475614EFA3F6Q39215865-D85350BE-2FE0-43CF-9842-549B159F4EDBQ39369199-4CF9494A-41A2-4539-B5BD-9980BCACF4F7Q39408105-F8AFDB64-274A-4ADE-B4C1-BEF62188F6C7Q40074591-68AD5129-6773-44AC-B327-C58D7C528D8FQ40099075-3E680D9E-C3D0-42E0-BB6B-FB860434BF6BQ42229717-900EAFE0-7209-4043-860E-82F8A49D0745Q42240280-7ECDDA20-AF5D-4674-9A5A-BEA7164C7854Q51389976-2EC0CBE8-D0A9-4ED8-9BB2-B29EC375B050Q56890070-86CDE700-2CB6-46CB-AB45-30BFF7774AEF
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immunotherapy for metastatic solid cancers
@ast
Immunotherapy for metastatic solid cancers
@en
Immunotherapy for metastatic solid cancers
@nl
type
label
Immunotherapy for metastatic solid cancers
@ast
Immunotherapy for metastatic solid cancers
@en
Immunotherapy for metastatic solid cancers
@nl
prefLabel
Immunotherapy for metastatic solid cancers
@ast
Immunotherapy for metastatic solid cancers
@en
Immunotherapy for metastatic solid cancers
@nl
P2860
P1433
P1476
Immunotherapy for metastatic solid cancers
@en
P2093
Simon Turcotte
Steven A Rosenberg
P2860
P304
P356
10.1016/J.YASU.2011.04.003
P577
2011-01-01T00:00:00Z